Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Roper

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Nature and Science|June 2, 2015
Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma CellsDiana L Borgas, Jin-Song Gao, Ming Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemiaXavier Leleu, Wanling Xie, Meghan Bagshaw, et al.
Cancers|June 2, 2021
The Immunotherapy Landscape in Adrenocortical CancerGuillaume J Pegna, Nitin Roper, Rosandra N Kaplan, et al.
Cancers|February 15, 2022
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical ImplicationsSakshi Jhawar, Yasuhiro Arakawa, Suresh Kumar, et al.
Cancer Research Communications|January 26, 2024
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung CancerNitin Roper, Rajaa El Meskini, Tapan Maity, et al.
Journal of the National Cancer Institute|September 6, 2014
Adult cancer clinical trials that fail to complete: an epidemic?Kristian D Stensland, Russell B McBride, Asma Latif, et al.
Acta Neuropathologica|May 15, 2008
Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expressionJade J Carter, Ming Tong, Elizabeth Silbermann, et al.
JTO Clinical and Research Reports|September 29, 2025
Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 StudyAzam Ghafoor, Nitin Roper, Chul Kim, et al.
Molecular & Cellular Proteomics : MCP|January 9, 2019
Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879VXu Zhang, Khoa Dang Nguyen, Paul A Rudnick, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinomaAnjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Nature and Science|June 2, 2015
Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma CellsDiana L Borgas, Jin-Song Gao, Ming Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemiaXavier Leleu, Wanling Xie, Meghan Bagshaw, et al.
Cancers|June 2, 2021
The Immunotherapy Landscape in Adrenocortical CancerGuillaume J Pegna, Nitin Roper, Rosandra N Kaplan, et al.
Cancers|February 15, 2022
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical ImplicationsSakshi Jhawar, Yasuhiro Arakawa, Suresh Kumar, et al.
Cancer Research Communications|January 26, 2024
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung CancerNitin Roper, Rajaa El Meskini, Tapan Maity, et al.
Journal of the National Cancer Institute|September 6, 2014
Adult cancer clinical trials that fail to complete: an epidemic?Kristian D Stensland, Russell B McBride, Asma Latif, et al.
Acta Neuropathologica|May 15, 2008
Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expressionJade J Carter, Ming Tong, Elizabeth Silbermann, et al.
JTO Clinical and Research Reports|September 29, 2025
Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 StudyAzam Ghafoor, Nitin Roper, Chul Kim, et al.
Molecular & Cellular Proteomics : MCP|January 9, 2019
Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879VXu Zhang, Khoa Dang Nguyen, Paul A Rudnick, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinomaAnjali Dhall, Daiki Taniyama, Fathi Elloumi, et al.
Pageof 5